1. Aracamone F, Bernardi L, Giardino P, DiMarco A, Casazza AM, Pratesi G (1976) Synthesis and antitumor activity of 4-demethoxy-daunorubicin, 4-demethoxy-7,9-diepidaunorubicin and their ?-anomes. Cancer Treat Rep 60:829?834
2. Benjamin RS, Riggs CE, Bachur VR (1973) Pharmacokinetics and metabolism of adriamycin in man. Clin Pharmacol Ther 14:592?600
3. Berman E, Witters R, Leyland Jones B, Casper ES, Gralla RJ, Howard J, Williams L, Baratz R, Young CW (1983) Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer. Cancer Res 43:6096?6101
4. Casazza AM (1979) Experimental evaluation of anthracycline analogues. Cancer Treat Rep 63:835?844
5. Casazza AM, DiMarco A, Bonadonna G, Bonfante V, Bertazzali C, Bellini O, Pratesi G, Sala L, Ballerini L (1979a) Effects of modifications in position 4 of the chromphore is position 4 of the amino sugar in the antitumor activity and toxicity of daunorubicin and doxorubicin. In: Crooke ST, Reich SD (eds) Anthracyclines: current status and new developments. Academic, New York, pp 403?430